Sectors

Condé Nast and Kering joined new and returning investors to back a round valuing the fashion item resale platform in excess of $1bn.

SoftBank and Microsoft have helped the last-mile delivery service increase its valuation to roughly $2bn in a round led by CapSur Capital.

Access Industries is set to exit the cloud infrastructure technology developer, which has filed to raise up to $100m on the New York Stock Exchange.

China Unicom has helped the Shanghai Electric-backed computer chip developer close a series C round that will fund commercialisation and research and development.

GV returned to help heart disease drug developer Tenaya boost its overall funding to approximately $248m.

Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

Eli Lilly-backed inflammatory disease drug developer has filed to raise up to $100m in an initial public offering in the United States.

IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

Hovione Scientia and Consort Medical-backed Oxular has secured funding that will support phase 2 trials for a treatment for diabetic macular oedema.

Carisma Therapeutics has increased its series B round to $59m thanks to an extension backed by IP Group, Penn Medicine and 4Bio Capital.

Cision, already a shareholder in the social media analytics provider, is set to pay $450m to acquire it, following $63m in funding.